ClinicalTrials.gov
ClinicalTrials.gov Menu

Biomarker for Gangliosidosis: BioGM1 / BioGM2 (BioGM1/BioGM2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02298647
Recruitment Status : Recruiting
First Posted : November 24, 2014
Last Update Posted : January 10, 2019
Sponsor:
Information provided by (Responsible Party):
Centogene AG Rostock

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : August 2021
  Estimated Study Completion Date : August 2021